Keren Haruvi

Keren Haruvi is the current President of Sandoz US and Head of North America at Sandoz. Keren has over 17 years of experience in the pharmaceutical industry.

Haruvi started their career at Teva Pharmaceuticals in December 2003 as SVP, Global Business Development and Alliance Management. Keren spent over 14 years at Teva in a variety of leadership roles before moving to Novartis in November 2017 as Global Head of M&A. Haruvi spent 3 years at Novartis before joining Sandoz in December 2020.

Keren Haruvi has an MBA from Bar-Ilan University with a specialization in finance, as well as a Bachelor of Arts in economics and Bachelor of Science in chemistry from Tel Aviv University.

Their manager is Richard Saynor, CEO. Some of their coworkers include Martin Bischof - Head, Ethics, Risk & Compliance, Ingrid Sollerer - General Counsel & Global Head, Legal, and Tatiana Eliseeva - Chief Transformation Officer.